<?xml version="1.0" encoding="UTF-8"?>
<p>4-(4-(1-(3-Chloro-benzyl)-1H-indol-3-yl)butanamido)-N-hydroxybenzamide (
 <bold>I9</bold>). HRMS (AP-ESI) 
 <italic>m/z</italic> calcd for C
 <sub>26</sub>H
 <sub>24</sub>ClN
 <sub>3</sub>O
 <sub>3</sub> [M + H]
 <sup>+</sup> 463.14767, found 462.15634. 
 <sup>1</sup>H NMR (400 MHz, DMSO) 
 <italic>δ</italic> 11.08 (s, 1H), 10.11 (s, 1H), 8.92 (s, 1H), 7.70–7.64 (m, 4H), 7.56 (d, 
 <italic>J</italic> = 7.8 Hz, 1H), 7.41 (d, 
 <italic>J</italic> = 8.2 Hz, 1H), 7.35–7.29 (m, 3H), 7.25 (s, 1H), 7.13–7.08 (m, 2H), 7.03–6.99 (m, 1H), 5.38 (s, 2H), 2.75 (t, 
 <italic>J</italic> = 7.2 Hz, 2H), 2.41 (t, 
 <italic>J</italic> = 7.3 Hz, 2H), 2.02–1.94 (m, 2H); 
 <sup>13</sup>C NMR (400 MHz, DMSO): 
 <italic>δ</italic> = 172.04, 164.41, 142.35, 141.55, 136.51, 133.59, 130.93, 128.27, 128.12, 127.71, 127.39, 127.26, 126.70, 126.12, 121.82, 119.28, 119.12, 118.73, 114.81, 110.44, 48.66, 36.67, 26.20, 24.62 ppm.
</p>
